CL2004000625A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES TOLTERODINE AND COCOA POWDER; ITS USE IN THE MANUFACTURE OF USEFUL DRUG FOR THE TREATMENT OF HYPERACTIVE BLADDER. - Google Patents

PHARMACEUTICAL COMPOSITION THAT INCLUDES TOLTERODINE AND COCOA POWDER; ITS USE IN THE MANUFACTURE OF USEFUL DRUG FOR THE TREATMENT OF HYPERACTIVE BLADDER.

Info

Publication number
CL2004000625A1
CL2004000625A1 CL200400625A CL2004000625A CL2004000625A1 CL 2004000625 A1 CL2004000625 A1 CL 2004000625A1 CL 200400625 A CL200400625 A CL 200400625A CL 2004000625 A CL2004000625 A CL 2004000625A CL 2004000625 A1 CL2004000625 A1 CL 2004000625A1
Authority
CL
Chile
Prior art keywords
tolterodine
manufacture
treatment
pharmaceutical composition
cocoa powder
Prior art date
Application number
CL200400625A
Other languages
Spanish (es)
Inventor
Lindberg Fredrik Per Nils-Olof
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of CL2004000625A1 publication Critical patent/CL2004000625A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

FORMULACION FARMACEUTICA QUE CONTIENEN TOTRODINA QUE COMPRENDE CACAO EN POLVO, Y SU USO PARA TRATAR VEJIGA HIPERACTIVA.PHARMACEUTICAL FORMULATION CONTAINING TOTRODIN THAT INCLUDES COCOA POWDER, AND ITS USE TO TREAT HYPERACTIVE BLADDER.

CL200400625A 2003-03-26 2004-03-24 PHARMACEUTICAL COMPOSITION THAT INCLUDES TOLTERODINE AND COCOA POWDER; ITS USE IN THE MANUFACTURE OF USEFUL DRUG FOR THE TREATMENT OF HYPERACTIVE BLADDER. CL2004000625A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300830A SE0300830D0 (en) 2003-03-26 2003-03-26 New formulations and use thereof

Publications (1)

Publication Number Publication Date
CL2004000625A1 true CL2004000625A1 (en) 2005-01-07

Family

ID=20290785

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400625A CL2004000625A1 (en) 2003-03-26 2004-03-24 PHARMACEUTICAL COMPOSITION THAT INCLUDES TOLTERODINE AND COCOA POWDER; ITS USE IN THE MANUFACTURE OF USEFUL DRUG FOR THE TREATMENT OF HYPERACTIVE BLADDER.

Country Status (12)

Country Link
EP (1) EP1605920A1 (en)
JP (1) JP2006521347A (en)
CN (1) CN1764441A (en)
AR (1) AR043773A1 (en)
AU (1) AU2004224556A1 (en)
BR (1) BRPI0408743A (en)
CA (1) CA2519119A1 (en)
CL (1) CL2004000625A1 (en)
MX (1) MXPA05010314A (en)
SE (1) SE0300830D0 (en)
WO (1) WO2004084864A1 (en)
ZA (1) ZA200506710B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1907136B (en) * 2006-07-28 2010-08-25 张新生 Vegetation health care milk-like liquid and preparation method thereof
KR101660666B1 (en) 2007-06-13 2016-09-27 오츠카 세이야쿠 가부시키가이샤 Equol-containing food
JP5702926B2 (en) 2009-10-16 2015-04-15 東レ・ダウコーニング株式会社 Treatment composition for wiping paper

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB918955A (en) * 1960-05-19 1963-02-20 Thomae Gmbh Dr K Pharmaceutical laxative compositions comprising 4,4-dihydroxy-2-amino triphenylmethane
SE9803986D0 (en) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
JP2001114668A (en) * 1999-10-13 2001-04-24 Meiji Seika Kaisha Ltd Chocolate preparation
DE60021749T2 (en) * 1999-11-11 2006-04-20 Pfizer Health Ab PHARMACEUTICAL FORMULATION CONTAINING TOLTERODINE AND ITS USE

Also Published As

Publication number Publication date
CN1764441A (en) 2006-04-26
AR043773A1 (en) 2005-08-10
JP2006521347A (en) 2006-09-21
SE0300830D0 (en) 2003-03-26
CA2519119A1 (en) 2004-10-07
AU2004224556A1 (en) 2004-10-07
WO2004084864A1 (en) 2004-10-07
BRPI0408743A (en) 2006-03-28
ZA200506710B (en) 2006-11-29
MXPA05010314A (en) 2006-05-19
EP1605920A1 (en) 2005-12-21

Similar Documents

Publication Publication Date Title
CR8642A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS
AR047928A1 (en) TETRAHYDROPIRIDOINDOL DERIVATIVES
UY29796A1 (en) NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
CL2009000035A1 (en) Derived compounds 3-spiro-heterocyclo-1yl-5h-cyclopentan [d] pyrimidine-indole, useful for inhibiting the activity of akt kinase; pharmaceutical composition comprising said compounds; and use in the treatment of diseases such as cancer, cystic fibrosis, diabetes, Alzheimer's disease, among others.
UY28342A1 (en) NEW COMPOUNDS
IL190951A0 (en) Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
CL2008001813A1 (en) COMPOUNDS DERIVED FROM QUINOLIN-3-CARBONITRILE SUBSTITUTED WITH PIPERAZINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS ARTHRITIS, INFLAMMATION, CANCER BETWEEN OTHERS (DIV. SOL. 266-04).
UY31673A1 (en) "UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211"
BRPI0510428A (en) methadone topical compositions and processes for using them
CL2007003640A1 (en) COMPOUNDS DERIVED FROM BENZAMIDA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT IN WHICH THE AFFECTION IS PAIN, SUCH AS LUMBAR AND CERVICAL PAIN, MIGRANA, DISMENORREA, PAIN PAIN, AMONG OTHERS.
ECSP088763A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF DEPRESSION
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
CL2011000144A1 (en) Compounds derived from benzo (1,4) dioxin-2-ylmethyl-sulfamide; pharmaceutical compositions containing them; process to prepare them and use in the treatment of anxiety, epilepsy, pain, substance abuse, related disorders, among others.
BRPI0312649A2 (en) compounds, pharmaceutical compositions containing them, and processes of use therefor.
CL2007003356A1 (en) COMPOUNDS DERIVED FROM BENZOPIRAZOLES; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE FOR THE TREATMENT OF ASTHMA, INFLAMMATION, AMONG OTHER DISEASES.
CL2008002247A1 (en) Compounds derived from phenyl amide; Preparation process; pharmaceutical composition containing them; and its use in the preparation of drugs for the treatment of sleep disorders, narcolepsy and psychiatric disorders, among others.
CL2011003144A1 (en) Crystalline form e3 of atazanavir bisulfate; pharmaceutical composition comprising it; Useful for the treatment of diseases caused by retroviruses (divisional of the application 1057-05).
CL2011002675A1 (en) Use of compounds derived from 9-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl-methyl nitrate or sulfate to reduce intraocular pressure; ophthalmic pharmaceutical composition comprising the compounds; and ophthalmic formulation of topical use that includes them.
ECSP088366A (en) 1,2-DIARILIMIDAZOLES FOR USE AS CB1 MODULATORS
CL2008002545A1 (en) Phenoxy-benzyl-carbamoyl derived compounds; pharmaceutical composition; process for preparing the pharmaceutical composition; and its use in the treatment of pain.
DK1893237T3 (en) Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active substance
CL2008002082A1 (en) Compounds derived from 6-phenyl-1h-imidazo [4,5-c] pyridine-4-carbonitrile, inhibitors of cathepsin s and cathepsin k; pharmaceutical composition; and use in the treatment of osteoporosis, atherosclerosis, inflammation, among other diseases.
CL2008000495A1 (en) Compounds derived from tetrahydro-pyrazolo [4,3-c] pyridine; pharmaceutical composition; and use in the treatment of diseases such as allergies, inflammation, pain, cancer, among others.
BRPI0516464B8 (en) method for preparing a pharmaceutical product